BIOMEDIT LLC
Microbial therapeutics discovered and designed from animal microbiomes
New patent ·
- Sector
- Biotech
- Headquarters
- FISHERS, IN
- Founded
- 2022
- Latest Form D
- $16M, Jun 2025
- Total capital
- $16.4M
- Federal grants
- $385K
- 2 awards · 2025–2026
- Rank in peer group#30 of 79
- Private capital raised
- $16M
- 1 Form D · last Jun 2025
- 16 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 26 pending · first 2026
- Rank in peer group#23 of 79
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Lactobacillus-vectored Alkaline Phosphatase to Mitigate Alcohol-induced Leaky Gut and LPS Endotoxin Load in the Gut$253K
- Private capital raisedForm D · SEC · 1st filing$16M
- Federal grantHealth and Human S · Phase I · Lactobacillus-vectored Alkaline Phosphatase to Mitigate Alcohol-induced Leaky Gut and LPS Endotoxin Load in the Gut$132K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
1month
from BIOMEDIT LLC’s first federal award to its first private round.
- First federal award · May 2025
- Health and Human S · $132K
- First Form D · Jun 2025
- $16M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 79 peers
Line = medianBiotech · System
- Federal grants#30 · top 38%
- Granted patents#23 · top 29%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Aaron SchachtExecutive Officer, DirectorNamed in SEC Form D filings
- Barbara BodemDirectorNamed in SEC Form D filings
- Brett WongDirectorNamed in SEC Form D filings
- Bruce SchelkopfExecutive OfficerNamed in SEC Form D filings
- Patrick JamesDirectorNamed in SEC Form D filings
- Paul CasadyDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 27- New patentProbiotic Bacillus Compositions And Methods Of UseUSPTOUS 12,746,261
- PendingProbiotic Lactobacillus Strain Compositions And Applications Therefor Including For Leaky Gut And InflammationUSPTOApplication 18704175
- PendingVhh Antibodies Targeting Fimh And Methods Of Using The SameUSPTOApplication 18694164
Show all 27 patent records
- Probiotic Bacillus Compositions And Methods Of UseSep 29, 2026 · US 12,746,261Granted
- Probiotic Lactobacillus Strain Compositions And Applications Therefor Including For Leaky Gut And InflammationMay 21, 2026 · Application 18704175Pending
- Vhh Antibodies Targeting Fimh And Methods Of Using The SameOct 2, 2025 · Application 18694164Pending
- Probiotic Compositions For AquacultureSep 25, 2025 · Application 18692412Pending
- Methods For Preserving Healthy Intestinal Microbiome During Growth Promoter AdministrationMay 22, 2025 · Application 18694065Pending
- Antimicrobial PeptidesJan 30, 2025 · Application 18693600Pending
- Heat Tolerant Alkaline PhosphataseJan 9, 2025 · Application 18712348Pending
- Lysostaphin Variants And Methods Of Use ThereofNov 28, 2024 · Application 18694162Pending
- Methods of Inhibiting Diseases Caused by Respiratory VirusesNov 28, 2024 · Application 18694118Pending
- Genetically Modified Bacillus Subtilis Strain And Use As A Live Delivery And Production SystemNov 28, 2024 · Application 18693585Pending
- Methods Of Inhibiting Diseases Caused By Respiratory VirusesApplication PCTUS2022044454Pending
- Genetically Modified Bacillus Subtilis Strain And Use As A Live Delivery And Production SystemApplication PCTUS2022044211Pending
- Antimicrobial PeptidesApplication PCTUS2022044221Pending
- Multivalent Anti-campylobacter Antibodies And VaccineApplication PCTUS2022044131Pending
- Probiotic Compositions For AquacultureApplication PCTUS2022043996Pending
- Probiotic Bacillus Compositions And Methods Of UseApplication PCTUS2021051973Pending
- Combating Necrotic Enteritis With L. Reuteri Vectored NanobodiesApplication 63750234Pending
- Probiotics To Reduce Greenhouse Gas Emissions In CattleApplication 63453894Pending
- DODECA-2,4,6,8,10-PENTAENOIC Acid Compositions And Uses ThereofApplication 63624335Pending
- Dual Agonists Against GLP-1R and GIPR and Methods of Use ThereofApplication 63540427Pending
- Stabilized GLP-1 and methods of use thereofApplication 63529271Pending
- Stabilized GLP-1 Peptides And Dual Agonist Peptides Against GLP-1R And Gipr And Methods Of Use ThereofApplication 63720000Pending
- Heat Tolerant Alkaline PhosphataseApplication PCTUS2022051325Pending
- Probiotic Lactobacillus Strain Compositions And Applications Therefor Including For Leaky Gut And InflammationApplication PCTUS2022047847Pending
- Vhh Antibodies Targeting Fimh And Methods Of Using The SameApplication PCTUS2022044361Pending
- Methods For Preserving Healthy Intestinal Microbiome During Growth Promoter AdministrationApplication PCTUS2022044403Pending
- Lysostaphin Variants And Methods Of Use ThereofApplication PCTUS2022044348Pending
Related companies, and why
- TALUS BIOSCIENCE, INC.Similar federal contract value in Biotech · null in contracts
- Hummingbird Nano, Inc.Similar federal contract value in Biotech · null in contracts
- Upstream BioSimilar federal contract value in Biotech · null in contracts
- ELGIA THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- WHITE ROCK THERAPEUTICSSimilar federal contract value in Biotech · null in contracts
- Neogene TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .